Skip to content
God Of Sound – Lifestyle
Author:
OKYO Pharma LTD
OKYO Pharma Announces Chief Development Officer and Director Acquires Shares
March 19, 2026
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
March 18, 2026
←
Previous Page
1
2